2016~2022

Safety and Health Management System ISO45001 Certification

Launched Health Supplement Brand: CUREKA

Secured ISO 37001 International Standard Anti-bribery Management Systems

Achieved grade A from Korea Fair Trade Commission’s Fair Trade Compliance Program

Introduced Apniben Q Sol. to the Korean market (Korea’s first Diclofenac mouthwash for oral inflammation)

2011~2015

Passed the Japan PMDA’s due diligence (Pharmaceuticals and Medical Devices Agency)

2014 Secured permit to export finished drugs to Japan

2013 Overseas manufacturing site certification in Japan

2011 Received the Sharing Practice Merit (Ministry of Health and Welfare)

2006~2010

Introduced Foster to Korean market (composite inhaled asthma treatment)

2008 Awarded the Outstanding Labor Relationship Award (Ministry of Employment and Labor)

Released Topisol for Korean market (Korea’s inaugural lotion type MPA)

1994~2005

Bicogreen: Winner of the First Brand Award (The Korea Economic Daily)

Launched Curosurf for Korean market (treatment for infantile respiratory distress syndrome)

Recognized as a BGMP company (Ministry of Food and Drug Safety No. 49)

Released Comy Syrup in Korean market (sinus cold remedy)

Certified as KGSP company (Ministry of Health and Welfare No. 116)

Launched Bicogreen tablet in Korea (treatment for constipation)

1958~1993

1992 Recognized as a KGMP company (Ministry of Health and Welfare No. 105)

1992 Established the Daejun Factory under KGMP

1990 Rebranded as KOLON Pharma

1989 Entered a technology alliance with Nippon Organon

1983 Became an affiliate of KOLON Group

1958 Founded as “Samyeong Chemical”